Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ICMT | O60725 | 3/20 | 0.39 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.37 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.35 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | MAT2A | P31153 | 1/20 | 0.33 |
| ▸ | SLC11A2 | P49281 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26536943 | 0.95 | PTPN5 (0.40) | ICMTPTPN5KDM4ENR3C1PGR | |
| SCHEMBL26529437 | 0.89 | ICMT (0.40) | ICMTPTPN5ENPP1SERPINE1PDK2 | |
| SCHEMBL26529096 | 0.89 | ICMT (0.43) | ICMTPTPN5ARKDM4EMAT2A | |
| SCHEMBL26529294 | 0.87 | ICMT (0.40) | ICMTPTPN5ENPP1PDK2AR | |
| SCHEMBL26529261 | 0.86 | ICMT (0.42) | ICMTPTPN5ENPP1SERPINE1PDK2 | |
| SCHEMBL26528830 | 0.84 | ICMT (0.37) | ICMTPTPN5SERPINE1HSD11B1TRPA1 | |
| SCHEMBL26536236 | 0.83 | TRPA1 (0.40) | ICMTARHSD11B1NR3C1PGR | |
| SCHEMBL26529193 | 0.83 | ICMT (0.37) | ICMTSERPINE1 | |
| SCHEMBL26539537 | 0.83 | ICMT (0.37) | ICMTSERPINE1KDM4ESLC11A2NR3C1 | |
| SCHEMBL26529215 | 0.83 | KIF11 (0.41) | ICMTPTPN5SERPINE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | P&h Tech Co., Ltd. (KR) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | ORMDL3, OR10J3, ORC3 | ICMT 36/4885PTPN5 1909/4885ENPP1 1414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.